In addition, increased TET1 expression was associated with the poor survival of patients with cytogenetically normal acute myeloid leukemia (CN-AML) [107], suggesting that TET1 may play a role as an oncogene in AML. This evidence concerns the gene TET1 and acute myeloid leukemia.